Purchase Order N0017817P6151
- Not listed
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a firm fixed price purchase order awarded by the Department of the Navy's Naval Supply Systems Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract, valued at $135,878.00, is for the provision of a NovaSeq sequencing system, related consumables, and a 0.25 maintenance plan. The contract has a completion date of January 12, 2025 and was awarded on December 28, 2023. This award does not appear to be associated with a larger...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc. for the provision of ILLUMINA SUPPLIES. The contract has a ceiling value of $302,813.03 and a period of performance through March 19, 2025. No set-aside was used. Illumina is an established provider of sequencing and genomic analysis instruments and reagents, having supported research and diagnostic needs across various federal...
- This is a $194,653.66 firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc. for the provision of sequencing instruments, reagents, and related services. The contract, which does not have a set-aside designation, supports Illumina's provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables, sample prep kits, sequencing chips, maintenance, and bioinformatics...
- This firm fixed-price delivery order contract was awarded by the Plains Area agency of the U.S. federal government to Illumina, Inc. for the provision of two Illumina sequencing systems (SN: VH00839 & VH00841) and associated services. The total ceiling value of the contract is $90,150.80 and the ultimate completion date is January 3, 2025. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has a history of prior federal contract and sub-contract...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at the Naval Medical Research Center's Biological Defense Research Directorate. The contract has no set-aside designation. Illumina has a history of providing sequencing solutions to various federal agencies, including the NIH, CDC, USDA, and VA, through both prime contracts and subcontracts.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Illumina Miseq PM | N0017817Q0094 | Department of the Navy Naval Sea Systems Command | Award Notice 1/1 | 7/11/17, 1:19 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 8/1/17 |